168 related articles for article (PubMed ID: 22398376)
1. Amyloid-β25-35 induces apolipoprotein D Synthesis and growth arrest in HT22 hippocampal cells.
Martínez E; Navarro A; Ordóñez C; Del Valle E; Tolivia J
J Alzheimers Dis; 2012; 30(2):233-44. PubMed ID: 22398376
[TBL] [Abstract][Full Text] [Related]
2. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
[TBL] [Abstract][Full Text] [Related]
3. Increased apolipoprotein D dimer formation in Alzheimer's disease hippocampus is associated with lipid conjugated diene levels.
Bhatia S; Jenner AM; Li H; Ruberu K; Spiro AS; Shepherd CE; Kril JJ; Kain N; Don A; Garner B
J Alzheimers Dis; 2013; 35(3):475-86. PubMed ID: 23455990
[TBL] [Abstract][Full Text] [Related]
4. Protective effects of bone morphogenetic protein 7 against amyloid-beta induced neurotoxicity in PC12 cells.
Sun L; Guo C; Liu D; Zhao Y; Zhang Y; Song Z; Han H; Chen D; Zhao Y
Neuroscience; 2011 Jun; 184():151-63. PubMed ID: 21496477
[TBL] [Abstract][Full Text] [Related]
5. Apolipoprotein D modulates amyloid pathology in APP/PS1 Alzheimer's disease mice.
Li H; Ruberu K; Muñoz SS; Jenner AM; Spiro A; Zhao H; Rassart E; Sanchez D; Ganfornina MD; Karl T; Garner B
Neurobiol Aging; 2015 May; 36(5):1820-33. PubMed ID: 25784209
[TBL] [Abstract][Full Text] [Related]
6. Amyloid-β peptide fibrils induce nitro-oxidative stress in neuronal cells.
Ill-Raga G; Ramos-Fernández E; Guix FX; Tajes M; Bosch-Morató M; Palomer E; Godoy J; Belmar S; Cerpa W; Simpkins JW; Inestrosa And NC; Muñoz FJ
J Alzheimers Dis; 2010; 22(2):641-52. PubMed ID: 20858976
[TBL] [Abstract][Full Text] [Related]
7. The protective effect of curcumin on Aβ induced aberrant cell cycle reentry on primary cultured rat cortical neurons.
Wang J; Zhang YJ; Du S
Eur Rev Med Pharmacol Sci; 2012 Apr; 16(4):445-54. PubMed ID: 22696871
[TBL] [Abstract][Full Text] [Related]
8. Selective reduction of hydroperoxyeicosatetraenoic acids to their hydroxy derivatives by apolipoprotein D: implications for lipid antioxidant activity and Alzheimer's disease.
Bhatia S; Knoch B; Wong J; Kim WS; Else PL; Oakley AJ; Garner B
Biochem J; 2012 Mar; 442(3):713-21. PubMed ID: 22150111
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein D mediates autocrine protection of astrocytes and controls their reactivity level, contributing to the functional maintenance of paraquat-challenged dopaminergic systems.
Bajo-Grañeras R; Ganfornina MD; Martín-Tejedor E; Sanchez D
Glia; 2011 Oct; 59(10):1551-66. PubMed ID: 21688324
[TBL] [Abstract][Full Text] [Related]
10. Probucol, a lipid-lowering drug, prevents cognitive and hippocampal synaptic impairments induced by amyloid β peptide in mice.
Santos DB; Peres KC; Ribeiro RP; Colle D; dos Santos AA; Moreira EL; Souza DO; Figueiredo CP; Farina M
Exp Neurol; 2012 Feb; 233(2):767-75. PubMed ID: 22173317
[TBL] [Abstract][Full Text] [Related]
11. Ferulic acid ethyl ester protects neurons against amyloid beta- peptide(1-42)-induced oxidative stress and neurotoxicity: relationship to antioxidant activity.
Sultana R; Ravagna A; Mohmmad-Abdul H; Calabrese V; Butterfield DA
J Neurochem; 2005 Feb; 92(4):749-58. PubMed ID: 15686476
[TBL] [Abstract][Full Text] [Related]
12. Acetyl-L-carnitine-induced up-regulation of heat shock proteins protects cortical neurons against amyloid-beta peptide 1-42-mediated oxidative stress and neurotoxicity: implications for Alzheimer's disease.
Abdul HM; Calabrese V; Calvani M; Butterfield DA
J Neurosci Res; 2006 Aug; 84(2):398-408. PubMed ID: 16634066
[TBL] [Abstract][Full Text] [Related]
13. Intracellular amyloid-β accumulation in calcium-binding protein-deficient neurons leads to amyloid-β plaque formation in animal model of Alzheimer's disease.
Moon M; Hong HS; Nam DW; Baik SH; Song H; Kook SY; Kim YS; Lee J; Mook-Jung I
J Alzheimers Dis; 2012; 29(3):615-28. PubMed ID: 22269161
[TBL] [Abstract][Full Text] [Related]
14. Mutations in amyloid precursor protein and presenilin-1 genes increase the basal oxidative stress in murine neuronal cells and lead to increased sensitivity to oxidative stress mediated by amyloid beta-peptide (1-42), HO and kainic acid: implications for Alzheimer's disease.
Mohmmad Abdul H; Sultana R; Keller JN; St Clair DK; Markesbery WR; Butterfield DA
J Neurochem; 2006 Mar; 96(5):1322-35. PubMed ID: 16478525
[TBL] [Abstract][Full Text] [Related]
15. Effects of a tacrine-8-hydroxyquinoline hybrid (IQM-622) on Aβ accumulation and cell death: involvement in hippocampal neuronal loss in Alzheimer's disease.
Antequera D; Bolos M; Spuch C; Pascual C; Ferrer I; Fernandez-Bachiller MI; Rodríguez-Franco MI; Carro E
Neurobiol Dis; 2012 Jun; 46(3):682-91. PubMed ID: 22426395
[TBL] [Abstract][Full Text] [Related]
16. Oligomerized Abeta25-35 induces increased tyrosine phosphorylation of NMDA receptor subunit 2A in rat hippocampal CA1 subfield.
Wu GM; Hou XY
Brain Res; 2010 Jul; 1343():186-93. PubMed ID: 20441772
[TBL] [Abstract][Full Text] [Related]
17. Galantamine protects against oxidative stress induced by amyloid-beta peptide in cortical neurons.
Melo JB; Sousa C; Garção P; Oliveira CR; Agostinho P
Eur J Neurosci; 2009 Feb; 29(3):455-64. PubMed ID: 19222556
[TBL] [Abstract][Full Text] [Related]
18. Oxidative stress induces apolipoprotein D overexpression in hippocampus during aging and Alzheimer's disease.
Martínez E; Navarro A; Ordóñez C; Del Valle E; Tolivia J
J Alzheimers Dis; 2013; 36(1):129-44. PubMed ID: 23568103
[TBL] [Abstract][Full Text] [Related]
19. Intracellular Abeta42 activates p53 promoter: a pathway to neurodegeneration in Alzheimer's disease.
Ohyagi Y; Asahara H; Chui DH; Tsuruta Y; Sakae N; Miyoshi K; Yamada T; Kikuchi H; Taniwaki T; Murai H; Ikezoe K; Furuya H; Kawarabayashi T; Shoji M; Checler F; Iwaki T; Makifuchi T; Takeda K; Kira J; Tabira T
FASEB J; 2005 Feb; 19(2):255-7. PubMed ID: 15548589
[TBL] [Abstract][Full Text] [Related]
20. Aging, gender and APOE isotype modulate metabolism of Alzheimer's Abeta peptides and F-isoprostanes in the absence of detectable amyloid deposits.
Yao J; Petanceska SS; Montine TJ; Holtzman DM; Schmidt SD; Parker CA; Callahan MJ; Lipinski WJ; Bisgaier CL; Turner BA; Nixon RA; Martins RN; Ouimet C; Smith JD; Davies P; Laska E; Ehrlich ME; Walker LC; Mathews PM; Gandy S
J Neurochem; 2004 Aug; 90(4):1011-8. PubMed ID: 15287908
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
